Family Communication Patterns and Challenges of Huntington's Disease Risk, the Decision to Pursue Presymptomatic Testing, and Test Results.


Journal

Journal of Huntington's disease
ISSN: 1879-6400
Titre abrégé: J Huntingtons Dis
Pays: Netherlands
ID NLM: 101589965

Informations de publication

Date de publication:
2020
Historique:
pubmed: 23 6 2020
medline: 31 8 2021
entrez: 23 6 2020
Statut: ppublish

Résumé

Communicating genetic information within families can provide individuals with the emotional support, alert family members to their own potential risk, and strengthen relationships. However, these communications have the potential to cause emotional distress to individuals and family members if family members are informed of a risk they do not wish to know or discuss. Communication about the decision to pursue testing and test results are especially sensitive in Huntington's disease (HD), where individuals often feel strongly about either knowing or not knowing their genetic status. To examine family communication patterns of genetic risk, the decision to pursue testing, and test results not just years, but decades after testing for HD, and examine how family communication of genetic risk information affects family relationships over the long-term. In this qualitative study, 39 semi-structured interviews were conducted with probands who went through genetic testing for HD. Clinic notes from these individuals were also analyzed. Family communication patterns varied based on relation (e.g., significant others, child, extended family) and were influenced by a variety of factors. Sharing with spouses and children had a positive influence on the relationship in most cases. Sharing with extended family members had varying effects on relationships. Negative effects were more likely when family members were in denial, had not pursued testing for themselves, or did not support testing. Communication to significant others and children, should be discussed with and supported in individuals seeking testing for HD, but for extended family members, potential effects on the relationship, emotional distress, and benefits should be discussed and weighed.

Sections du résumé

BACKGROUND
Communicating genetic information within families can provide individuals with the emotional support, alert family members to their own potential risk, and strengthen relationships. However, these communications have the potential to cause emotional distress to individuals and family members if family members are informed of a risk they do not wish to know or discuss. Communication about the decision to pursue testing and test results are especially sensitive in Huntington's disease (HD), where individuals often feel strongly about either knowing or not knowing their genetic status.
OBJECTIVE
To examine family communication patterns of genetic risk, the decision to pursue testing, and test results not just years, but decades after testing for HD, and examine how family communication of genetic risk information affects family relationships over the long-term.
METHODS
In this qualitative study, 39 semi-structured interviews were conducted with probands who went through genetic testing for HD. Clinic notes from these individuals were also analyzed.
RESULTS
Family communication patterns varied based on relation (e.g., significant others, child, extended family) and were influenced by a variety of factors. Sharing with spouses and children had a positive influence on the relationship in most cases. Sharing with extended family members had varying effects on relationships. Negative effects were more likely when family members were in denial, had not pursued testing for themselves, or did not support testing.
CONCLUSION
Communication to significant others and children, should be discussed with and supported in individuals seeking testing for HD, but for extended family members, potential effects on the relationship, emotional distress, and benefits should be discussed and weighed.

Identifiants

pubmed: 32568103
pii: JHD200402
doi: 10.3233/JHD-200402
pmc: PMC7569676
mid: NIHMS1633092
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

265-274

Subventions

Organisme : NHGRI NIH HHS
ID : R01 HG008045
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007814
Pays : United States

Références

Clin Genet. 2003 Oct;64(4):317-26
pubmed: 12974737
Fam Community Health. 2001 Oct;24(3):13-26
pubmed: 11563941
Am J Med Genet. 1994 Sep 15;54(3):174-84
pubmed: 7810575
Cancer Res Treat. 2016 Jan;48(1):384-92
pubmed: 25779366
J Genet Couns. 2011 Feb;20(1):70-9
pubmed: 20878217
Psychosom Med. 1997 May-Jun;59(3):269-79
pubmed: 9178338
J Genet Couns. 2008 Feb;17(1):117-28
pubmed: 17943424
Mol Genet Genomic Med. 2018 Nov;6(6):1140-1147
pubmed: 30393972
Bioethics. 2001 Jun;15(3):231-47
pubmed: 11700677
Nat Rev Neurol. 2014 Apr;10(4):204-16
pubmed: 24614516
Cancer. 2012 Jul 1;118(13):3417-25
pubmed: 22231763
Eur J Hum Genet. 2007 Oct;15(10):999-1011
pubmed: 17609674
An Sist Sanit Navar. 2012 May-Aug;35(2):295-307
pubmed: 22948430
Am J Med Genet. 2000 Jan 3;90(1):49-59
pubmed: 10602118
J Genet Couns. 2018 Jun;27(3):533-548
pubmed: 29383546
J Genet Couns. 2013 Feb;22(1):16-21
pubmed: 22833230
Int J Lang Commun Disord. 2010 May-Jun;45(3):381-93
pubmed: 20144006
Am J Med Genet C Semin Med Genet. 2008 Feb 15;148C(1):56-69
pubmed: 18200514
J Law Med Ethics. 2015 Fall;43(3):440-63
pubmed: 26479555
J Consult Clin Psychol. 2001 Aug;69(4):706-11
pubmed: 11550737
J Neuropsychiatry Clin Neurosci. 1989 Spring;1(2):195-7
pubmed: 2535311

Auteurs

Kelsey Stuttgen (K)

Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.
Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Juli Bollinger (J)

Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.

Allison McCague (A)

Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.
Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Rachel Dvoskin (R)

Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.

Debra Mathews (D)

Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH